Ying Zou

Associate Professor


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ying Zou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma

Duong, V. H., Holtzman, N. G., Koka, R., Singh, Z. N., Zou, Y., Emadi, A., Rapoport, A. P., Kocoglu, M. H., Baer, M. R. & Badros, A. Z., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Cryptic ETV6–PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasm

Singh, Z. N., Richards, S., El Chaer, F., Duong, V. H., Gudipati, M. A., Waters, E. O., Koon, S., Webley, M., Pitel, B., Hoppman, N. L., Baer, M. R. & Zou, Y., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1304-1307 4 p.

Research output: Contribution to journalLetter

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation

Adige, S., Lapidus, R. G., Carter-Cooper, B. A., Duffy, A., Patzke, C., Law, J. Y., Baer, M. R., Ambulos, N. P., Zou, Y., Bentzen, S. M. & Emadi, A., Jun 1 2019, In : Cancer Chemotherapy and Pharmacology. 83, 6, p. 1105-1112 8 p.

Research output: Contribution to journalArticle

  • Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation

    Lee, I., Gudipati, M. A., Waters, E., Duong, V. H., Baer, M. R. & Zou, Y., Nov 19 2019, In : Molecular Cytogenetics. 12, 1, 47.

    Research output: Contribution to journalArticle

    Open Access
  • Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia

    Holtzman, N. G., El Chaer, F., Baer, M. R., Ali, O., Patel, A., Duong, V. H., Sausville, E. A., Singh, Z. N., Koka, R., Zou, Y. S., Etemadi, A. & Emadi, A., Jan 1 2019, (Accepted/In press) In : British journal of haematology.

    Research output: Contribution to journalArticle